Previous Article | Next Article ![]()
Eukaryotic Cell, November 2005, p. 1801-1807, Vol. 4, No. 11
1535-9778/05/$08.00+0 doi:10.1128/EC.4.11.1801-1807.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Sarah E. Lewis,1
Benjamin C. Yan,2
Peter Orlean,2 and
David E. Levin1*
Department of Biochemistry & Molecular Biology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205,1 Department of Microbiology, University of Illinois, Urbana-Champaign, Urbana, Illinois 618012
Received 30 August 2005/ Accepted 7 September 2005
|
|
|---|
|
|
|---|
GPIs, which have the conserved core structure protein-CO-NH-CH2-CH2-PO4-6-mannose (Man)-
1,2-Man-
1,6-Man-
1,4-GlcN-
1,6-inositol-PO4-lipid, are preassembled at the endoplasmic reticulum (ER) in a multistep pathway prior to their transfer to target proteins (reviewed in references 8, 20, 25, 28, and 39). Many genes involved in the GPI anchoring pathway have been identified, and in most cases yeast and mammalian GPI assembly proteins display amino acid sequence similarity. Mutations blocking GPI assembly or transfer to proteins are lethal in yeast.
The first step in GPI assembly, the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to an acceptor phosphatidylinositol (PI) is catalyzed by a multiprotein complex that resides in the ER membrane. The human GPI-GlcNAc transferase complex is an unusually elaborate glycosyltransferase, possessing at least six subunits (44). Four of these, GPI1, PIG-A, PIG-C, and PIG-H, have structural and functional counterparts in the S. cerevisiae Gpi1, Gpi3, Gpi2, and Gpi15 proteins, respectively (15, 22, 23, 27, 31, 40, 42, 43, 46). Among these proteins, PIG-A/Gpi3 is the UDP-GlcNAc-binding and likely catalytic subunit, based both on its sequence similarity to members of a large family of glycosyltransferases (10, 18, 42) and on cross-linking studies using a photoactivatable analogue of UDP-GlcNAc (21). A potential fifth subunit of the mammalian complex has been identified only as a copurifying 5-kDa protein, which may be the homologue of the recently discovered Eri1 subunit of the S. cerevisiae complex, which is similar in size (37). Loss of function mutations in most subunits of the GPI-GlcNAc transferase completely blocks GPI synthesis. The only known exceptions to this are yeast Eri1 and human and yeast Gpi1; loss of either subunit in yeast results in a temperature-sensitive growth defect (23, 37).
The sixth identified subunit of the human GPI-GlcNAc transferase, PIG-P, shares 20% sequence identity to the product of an uncharacterized S. cerevisiae open reading frame of 140 codons, YDR437w (44). Interestingly, the human PIG-P gene, which resides on chromosome 21, is also known as DSCR5, for Down Syndrome critical region 5 (44). Down Syndrome (DS; trisomy 21) is the most common genetic cause of mental retardation. The PIG-P protein is overexpressed twofold in fetal DS brain tissue, leading to the suggestion that aberrant GPI anchoring interferes with brain development (9). Moreover, PIG-P is evidently the only DSCR gene that is expressed in tongue tissue, prompting the suggestion that its overexpression plays a role in the pathophysiology of tongue malformation in DS patients (4). We demonstrate here that YDR437w encodes an essential subunit of the yeast GPI-GlcNAc transferase, and we henceforth refer to this gene as GPI19 (for glycosylphosphatidylinositol anchor 19) in accordance with the nomenclature of other yeast genes involved in GPI anchor production.
|
|
|---|
was used to propagate all plasmids. Escherichia coli cells were cultured in Luria broth medium (1% Bacto tryptone, 0.5% Bacto yeast extract, 1% NaCl) and transformed to carbenicillin resistance by standard methods. |
View this table: [in a new window] |
TABLE 1. S. cerevisiae strains useda
|
Genomic deletion of GPI19, cloning, and plasmid construction.
To delete the genomic copy of GPI19 in the EG123 strain background, a DNA fragment spanning from 436 bp 5' of the GPI19 start codon to 16 bp 3' of the start codon was amplified by PCR from genomic DNA isolated from yeast strain 1783. A second fragment was amplified from 18 bp 5' of the GPI19 stop codon to 541 bp 3' of the stop codon. The 5' fragment was amplified with primers that placed an XbaI site at the end within the coding sequence and a BamHI site at the opposite end. The 3' fragment was amplified with primers that placed an ApaI site adjacent to the stop codon and a BamHI site at the opposite end. These fragments were ligated in a three-molecule reaction to the ApaI and XbaI sites of the integrative plasmid pRS305 (32) to create a unique BamHI site between the fragments. The resulting plasmid, pRS305[gpi19
::LEU2] (p1955), was linearized with BamHI and used to transform yeast strain 1788 to leucine prototrophy. The replacement of GPI19 sequences was confirmed by PCR. The heterozygous gpi19
::LEU2/GPI19 strain (DL2987) was induced to sporulate for tetrad dissection. Viable spores, which segregated 2:2 with inviable spores, were all leucine auxotrophs, confirming the lethality of the deletion.
To construct a genomic clone of GPI19, its coding and regulatory sequences were amplified by PCR from strain 1783 genomic DNA. A 1.1-kb genomic SspI fragment was cloned into the SmaI site of centromeric plasmid pRS316 (32) to yield pRS316[GPI19] (p1995). GPI19 was subcloned into centromeric plasmid pRS314 (32) using the KpnI and SacI sites within the polylinkers of both plasmids to yield pRS314[GPI19] (p1996).
A functional C-terminally hemagglutinin (HA)-tagged form of Gpi19 was constructed as described below. The GPI19 open reading frame was amplified from p1995 and subcloned into pYeF2 (6) using BamHI and NotI sites engineered into the primers. This construction (pYeF2[GPI19]; p2032) fuses Gpi19 in frame at its C terminus with a single copy of the HA epitope and places it under the inducible control of the GAL1 promoter. This plasmid was used to create HA-tagged Gpi19 fusions to invertase (Suc2) for topology studies. Full-length Gpi19-HA was fused to Suc2 by amplification of GPI19-HA with the GAL1 promoter from p2032 using primers that included a SacI site 5' to the GAL1 promoter and a SalI site immediately 3' of the HA coding sequence. This fragment was subcloned into the SacI/XhoI sites of pR90 (p2019) (19) to fuse the HA sequence in frame with SUC2. The resulting plasmid, pGAL1::GPI19-HA-SUC2 (p2040), was used to create a related fusion lacking the C-terminal 90 amino acid residues of Gpi19. The GAL1 promoter and the first 150 nucleotides of GPI19 coding sequence was amplified using the 5' GAL1 primer described above and a primer internal to the GPI19 coding sequence designed with a NotI site. This fragment was subcloned into the SacI/NotI sites of p2040 so as to fuse in frame the N-terminal 50 amino acid residues of Gpi19 with HA-Suc2 (pGAL1::GPI19C
-HA-SUC2; p2077).
Isolation of temperature-sensitive gpi19 mutants.
Error-prone PCR was used to generate random mutations within the GPI19 coding sequence. The GPI19 sequence was amplified from p1995 using Taq polymerase and the T7 and T3 primers to include the polylinker sequences on either side of GPI19. Errors were generated during amplification by two modifications to decrease fidelity of the Taq polymerase. First, 0.5 mM MnCl2 was included in each of four separate reactions. Second, a different deoxynucleotide in each of the four reactions was reduced in concentration from 1 mM to 0.1 mM. The products of the four reactions were combined and subcloned into the KpnI/SacI sites of pRS314 (32). Approximately 1,000 independent plasmid clones were isolated and transformed into yeast strain DL3050 (gpi19
::LEU2 pRS316[GPI19]) by selection for tryptophan prototrophy. Approximately 3,000 yeast transformants were double replica plated to 5-fluorootic acid (5-FOA)-containing medium (1) at 23°C and 37°C to evict the URA3-based plasmid bearing wild-type GPI19. Replicate colonies that grew in the presence of 5-FOA at low temperature but not at high temperature were isolated for further characterization. A total of eight such colonies were identified. Plasmids were isolated from these temperature-sensitive strains and retransformed into diploid strain DL2987 (gpi19
::LEU2/GPI19) for sporulation. DNA sequence analysis of these plasmids revealed that six different gpi19 alleles had been isolated. Mutation sites are available upon request.
The frameshift at codon 25 found among the mutations in both gpi19-5 and gpi19-6 was created in wild-type GPI19 by PCR-mediated site-directed mutagenesis (12) to generate gpi19-7 and was cloned into pRS314 (p2075). Tyr75 was converted to a stop codon (TAA) in gpi19-7 by the same method, creating gpi19-8, which was cloned into pRS314 (p2076). Mutations were confirmed by DNA sequence analysis of the entire GPI19 gene. All primer sequences are available upon request.
In vitro assays of GPI-GlcNAc transferase and Dol-P-mannose synthase. For GPI-GlcNAc transferase activity, membranes were prepared and assayed for in vitro synthesis of [14C]GlcNAc-PI using a slight modification of the method of Costello and Orlean (5) as described in Sobering et al. (37). The Dol-P-mannose synthase assay was carried out as described by Orlean et al. (29). Lipids were separated by thin-layer chromatography (TLC) on Kieselgel 60 (Merck) using chloroform:methanol:H2O (65:25:4 by volume), and radiolabeled lipids were visualized by fluorography.
Immunodetection of Gpi19 and Gpi2 in complex. For detection of the Gpi19-Gpi2 association, yeast strain 1788 was cotransformed to uracil and leucine dual prototrophy with pYeF2[GPI19] (which expresses Gpi19-HA under the control of the GAL1 promoter; p2032) and either pRS425MET25[FLAG-GPI2] (p1874) or pRS425[GPI2] (p1860). Transformants were precultured at 30°C in yeast extract peptone (YEP)-2% raffinose and induced for 4 h in YEP-4% galactose, and extracts were prepared as described previously (36). For immunoprecipitation of FLAG-Gpi2, extract (500 µg) was incubated with anti-FLAG M2 agarose beads (20 µl) or protein A-Sepharose (no antibody control) beads (in a 1:1 slurry; both from Sigma) in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA (pH 8.0), 5 mM EGTA (pH 8.0), 50 mM KF, 30 mM Na2PPi [pH 7.5], 1 mM Na3VO4, and 0.1% NP-40 at 4°C for 1 h with gentle agitation. Immune complexes were washed three times with the same buffer and solubilized in sodium dodecyl sulfate (SDS) sample buffer (final volume of 100 µl). Samples were loaded without heating (heating caused FLAG-Gpi2 to form aggregates), separated on SDS-polyacrylamide gels (8 to 16% gradient; Bio-Rad), and transferred to polyvinylidene difluoride membranes for immunoblot detection of FLAG-Gpi2 with anti-Flag M2 antibodies (Sigma) and of Gpi19-HA with anti-HA antibodies (12CA5; BabCo).
Other assays. For endoglycosidase H (Endo H) assays, transformants were grown in YEP plus 2% raffinose, followed by induction of Gpi19 fusions by addition of 2% galactose and further incubation at 30°C for 4 h. Cell lysates were prepared as described previously (17) but were supplemented with a final concentration of 80 mM potassium acetate, pH 5.6. Extracts (30 µg protein) were treated with 1.5 µl Endo H (1 U/200 µl) for 1 h at 37°C prior to separation on an SDS-polyacrylamide gel (7%; Bio-Rad) and transferred to PVDF membranes for immunoblot detection of Gpi19-HA-Suc2. Zymolyase sensitivity was measured as described previously (35).
|
|
|---|
and gpi1
mutants are hypersensitive to cell lysis by treatment with the cell wall lytic enzyme zymolyase (37). Similarly, we found that the gpi19 mutants were hypersensitive to zymolyase treatment (Fig. 1). Finally, the growth defects of eri1
and gpi1
mutants are suppressed by increased intracellular concentration of UDP-GlcNAc, a substrate for the GPI-GlcNAc transferase (37). This can be accomplished either by overexpression of GFA1, whose product catalyzes the production of glucosamine-6-phosphate, the first committed and rate-limiting step in the production of UDP-GlcNAc (28), or with exogenous glucosamine, which is converted to glucosamine-6-phosphate (3, 45). We found that the least severely impaired alleles of gpi19 (gpi19-1 and gpi19-2) were suppressed for their growth defects at restrictive temperature by either GFA1 overexpression or exogenous glucosamine (Fig. 2 and data not shown).
![]() View larger version (15K): [in a new window] |
FIG. 1. Temperature-sensitive gpi19 mutants are hypersensitive to lysis by treatment with the cell wall digestive enzyme zymolyase. The wild type (1788) and three gpi19 mutants, gpi19-1 (DL3107), gpi19-2 (DL3106), and gpi19-5 (DL3103), were grown in YEPD to mid-log phase at 23°C, washed, and resuspended in water to an initial density of A600 of 0.7 prior to treatment with zymolyase 20T (150 µg/ml). Cell lysis was assessed by A600 measurements at the indicated times.
|
![]() View larger version (59K): [in a new window] |
FIG. 2. Growth defects of conditional gpi19 mutants are suppressed by overexpression of GFA1. The gpi19-2 mutant (DL3106) was transformed with 2µ plasmid pRS202[GFA1] (37), centromeric plasmid pRS316[GPI19] (p1995), or pRS316 (vector). Transformants were streaked onto YEPD and incubated for 3 days at 37°C.
|
![]() View larger version (96K): [in a new window] |
FIG. 3. Conditional gpi19 mutants display filamentation and agar invasion at semipermissive temperatures. A. A conditional gpi19 mutant displays weak filamentous growth at semipermissive temperature. Single colonies of diploid yeast strains were photographed after growth for 24 h on YEPD plus 10% sorbitol at the indicated temperatures. Strains are the wild type (1788) and gpi19-2 (DL3106). B. A conditional gpi19 mutant displays agar invasive growth. The same strains as in panel A were streaked onto a YEPD plus 10% sorbitol plate and allowed to grow at 35°C for 2 days (total growth). Nonadherent cells were washed from the plate with distilled water, and the plate was incubated for an additional day at 23°C to reveal invasive growth. WT, wild type.
|
![]() View larger version (60K): [in a new window] |
FIG. 4. Gpi19 associates in vivo with Gpi2. Extracts from a wild-type yeast strain (1788), cotransformed with pYeF2[GPI19] (p2032; expresses Gpi19HA under the inducible control of the GAL1 promoter) and either pRS425MET25 [FLAG-GPI2] (p1874; constitutively expresses FLAG-Gpi2) or pRS425 [GPI2] (p1860; expresses untagged Gpi2), were processed for immunoprecipitation (IP) with -Flag antibodies. Input protein (30 µg) and a fraction of the IP corresponding to 30 µg of input protein were separated by SDS-polyacrylamide gel electrophoresis and subjected to immunoblot detection of FLAG-Gpi2 ( -FLAG; top panel) or Gpi19-HA ( -HA; lower panel). The asterisk indicates an -FLAG immunoglobulin G band in the IP lanes. The positions of molecular mass markers (MW) are indicated on the left.
|
mutants are likewise defective in in vitro GPI-GlcNAc transferase activity (22, 23, 37). The activity of a control ER enzyme, Dol-P-Man synthase, was normal in the same microsome preparations (Fig. 5, compare lanes 5 to 7 to lanes 8 to 10). Therefore, we conclude that Gpi19 is essential for GPI-GlcNAc transferase activity.
![]() View larger version (33K): [in a new window] |
FIG. 5. In vitro assay for GPI-GlcNAc transferase activity. Microsomal fractions (100 µg protein) from extracts of a gpi19-5 mutant (DL3089) and its isogenic wild-type strain (DL3099) were incubated with UDP-[14C]GlcNAc at 30°C for the indicated times to measure GPI-GlcNAc transferase activity. The same microsomal fractions (5 µg) were incubated with GDP-[14C]-Man and Dol-P to assay Dol-P-mannose synthase as a control ER enzyme activity (20s, 20-s incubation). The lipids were extracted, separated by TLC, and detected by fluorography. WT, wild type.
|
|
View larger version (12K): [in a new window] |
FIG. 6. Amino acid sequence of Gpi19. The putative transmembrane domains are underlined. The arrowhead indicates the position of the frameshift mutation in gpi19-5, gpi19-6, and gpi19-7. Potential sites for translational reinitiation are in boldface. The "X" indicates the position of the nonsense codon introduced into gpi19-7 to generate gpi19-8.
|
![]() View larger version (29K): [in a new window] |
FIG. 7. Membrane topology determination for Gpi19. A. Extracts from wild-type strain 1783, transformed with p2040 (expresses Gpi19-HA-Suc2), p2077 (expresses Gpi19C -HA-Suc2), or pRS314 (vector), were treated with endoglycosidase H to assess the N-glycosylation state. Samples (30 µg protein) were separated by SDS-polyacrylamide gel electrophoresis monitored by immunoblot detection of the HA epitope. B. Cartoon of Gpi19 topology within the ER membrane. The Gpi19C -HA-Suc2 fusion junction is indicated with an arrow.
|
mutant. Therefore, we tested the possibility that translation of this mutant was being reinitiated at an internal methionine codon. Reinitiation would occur within a cluster of four methionine residues situated in the second transmembrane domain between Met61 and Met74. We first created the same frameshift mutation after codon 24 in an otherwise wild-type allele by site-directed mutagenesis and confirmed that this allele (gpi19-7) confers temperature-sensitive growth to the gpi19
mutant (restrictive temperature of 34°C; data not shown). We further mutated the gpi19-7 allele by converting Tyr75 to a nonsense mutation (Fig. 6). The new allele (gpi19-8) failed to complement the gpi19
mutant, confirming that sequences 3' to the frameshift mutation were important for function of gpi19-7. This result indicates that translation of gpi19-7 is reinitiated between Met61 and Met74 and reveals that the N-terminal half (at least 60 residues) of Gpi19 is dispensable for function at low temperatures. |
|
|---|
The modest sequence similarity of Gpi19 with the human PIG-P subunit of the GPI-GlcNAc transferase suggested that it might be associated with the analogous yeast enzyme complex. We demonstrated by coimmunoprecipitation that Gpi19 associates in vivo with the Gpi2 GPI-GlcNAc transferase subunit. Moreover, temperature-sensitive gpi19 mutants were defective for in vitro GPI-GlcNAc transferase activity, confirming that Gpi19 is essential for this enzymatic step.
We present evidence that Gpi19 passes through the ER membrane twice such that both the N and C termini of Gpi19 are cytoplasmically oriented, consistent with previous predictions (8, 44). However, two of the temperature-sensitive mutants we isolated resulted from frameshift mutations that led to translational reinitiation at a methionine codon in the middle of the GPI19 coding sequence. These results revealed that the N-terminal half of this protein, including the first transmembrane domain and the lumenal loop, is dispensable for function. We interpret this to mean that the second transmembrane domain is sufficient for proper localization and function of Gpi19.
Complexity of the GPI-GlcNAc transferase. Both the yeast and mammalian GPI-GlcNAc transferases are unusually elaborate enzyme complexes compared to other glycosyltransferases. Although PIG-A/Gpi3 appears to be the catalytic subunit, the roles of other subunits have not been firmly established. PIG-C/Gpi2 may function as a scaffold to anchor the complex to the ER membrane and facilitate interaction among other subunits (8). The nonessential Gpi1 subunit has been speculated to provide a stabilizing role for the GPI-GlcNAc transferase (13). The additional subunits may also provide sites for binding of regulatory proteins. For example, DPM2, a regulator of Dol-P-Man synthase, which is also required for GPI synthesis, associates with and stimulates the mammalian GPI-GlcNAc transferase through interactions with PIG-A, PIG-C, and GPI1 (44). Additionally, the small G-protein Ras2 associates with and inhibits the yeast GPI-GlcNAc transferase (37), although the subunit with which Ras2 associates has not yet been established.
The yeast genome database (www.yeastgenome.org) offers some intriguing connections between subunits of the GPI-GlcNAc transferase and later steps in GPI anchor biosynthesis and attachment. For example, large-scale two-hybrid analysis revealed that Gpi19 associates with an uncharacterized ER-localized protein, Yjr015w (11, 14). Two-hybrid screening also indicates that Yjr015w associates by two hybrid with the Gpi14 GPI-mannosyltransferase (11) and the Gpi16 subunit of the GPI-transamidase complex (41). Similarly, a recent large-scale two-hybrid study of yeast integral membrane proteins revealed interactions between Gpi2 and Gpi16, Gpi7, and Gwt1 (26). Gpi7 is a subunit of the phosphoethanolamine transferase complex proposed to catalyze a late step in GPI synthesis, and Gwt1 is required for the third step in GPI synthesis, inositol acylation. These interactions suggest that various enzymes along the pathway of GPI anchor biosynthesis and attachment are physically connected to the GPI-GlcNAc transferase. Thus, one role of this unusually elaborate complex may be to regulate the activities of enzymes that catalyze subsequent steps in the GPI synthesis pathway.
This work was supported by NIH grants GM67698 (D.E.L.) and GM46220 (P.O.). NCI training grant 5T32CA09110 supported M.J.R.
Present address: Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892. ![]()
|
|
|---|
-mannosyltransferases. Biochem. J. 318:133-138.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»